In 2024, the American Association of Tissue Banks (AATB) underwent a comprehensive strategic planning process that identified the need to strengthen and protect our association’s ability to engage in advocacy, policy, and industry promotion.
AATB has learned that the US Food and Drug Administration (FDA) has reissued the following guidance documents as drafts, with a public comment period open through July 7, 2025.
On April 18, 2025, the White House Office of Management and Budget (OMB) received the two guidance documents from the US Food and Drug Administration (FDA) for final review under the Administration’s mandate to evaluate guidance issued during the previous administration.
AATB is seeking nominations for the AATB Board of Governors in the following leadership positions: Chairperson-Elect, Secretary-Treasurer, and At-Large Governors (2).